Skip to main content
SpringerLink
Log in

Use of Monoclonal Antibodies to Fibrinogen, Fibrin and Fibrin(Ogen) Degradation Products in Atherosclerosis

  • Chapter
Atherosclerotic Plaques

Part of the book series: Nato ASI Series ((NSSA,volume 219))

  • 50 Accesses

Abstract

Fibrinogen is a soluble protein which is converted into an insoluble gel, fibrin, by thrombin. Fibrin formation is involved in the physiology of hemostasis and wound repair and in a number of pathological processes such as thrombosis, atherosclerosis, tumors, renal disease and inflammation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. H. L. Nossel, Relative proteolysis of the fibrinogen Bß thrombosis. Nature 291:165 (1981).

    Article  CAS  PubMed  Google Scholar 

  2. B. Blombäck, B. Hessel, D. Hogg, and L. Therkildsen, A two-step fibrinogen-fibrin transition in blood coagulation. Nature 257:501 (1978).

    Article  Google Scholar 

  3. A. Bini, J. J. Jr. Fenoglio, J. Sobel, J. Owen, M. Fejgl, and K.L. Kaplan, Immunochemical characterization of fibrinogen, fibrin I, and fibrin II in human thrombi and atherosclerotic lesions. Blood 69:1038 (1987).

    PubMed  CAS  Google Scholar 

  4. A. Bini, J. Sobel and K.L. Kaplan, Separation and characterization of fibrinogen-derived fragments in human arterial thrombi, in: “Fibrinogen and its Derivatives”, Muller-Berghaus G., U. Scheefers-Borchel, E. Selmayr and A. Henschen ed., Elsevier Science Publishers, Amsterdam (1986).

    Google Scholar 

  5. A. Bini, J.J. Jr. Fenoglio., R. Mesa-Tejada, B.J. Kudryk, and K.L. Kaplan, Identification and distribution of fibrinogen, fibrin, and fibrin(ogen) degradation products in atherosclerosis. Arteriosclerosis 9:109 (1989).

    Article  CAS  PubMed  Google Scholar 

  6. K. L. Kaplan, A. Bini, Thrombosis in atherogenesis. Crit. Rev. Oncol. Hematol. 9:305 (1989).

    Article  CAS  PubMed  Google Scholar 

  7. R. Lorenzet, J.H. Sobel, A. Bini, and L.D. Witte, The release of mitogenic activity from endothelial cells is enhanced by low molecular weight fibrinogen-degradation products. Circulation 78:394 (1988).

    Google Scholar 

  8. G. Di Minno, and M. Mancini, Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 10:1 (1990).

    Article  PubMed  Google Scholar 

  9. W. B. Kannel, P.A. Wolf, W.P. Castelli, and R.B. D’Agostino, Fibrinogen and risk of cardiovascular disease. The Framingham study. J.A.M.A. 258:1183 (1987).

    Article  CAS  PubMed  Google Scholar 

  10. T. W. Meade, R. Chakrabarti, A. Haines, W.R.S. North, Y. Sitirling, and S.G. Thompson, Haemostatic function and cardiovascular death: Early results of a prospective study. Lancet 1:1050 (1980).

    Article  CAS  PubMed  Google Scholar 

  11. T. W. Meade, M.C. Brozovic, R.R. Chakrabarti, J.D. Imeson, S. Mellows, G.J. Miller, W.R.S. North, Y. Stirling, and S.G. Thompson, Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study. Lancet 11:533 (1986).

    Article  Google Scholar 

  12. L. Wilhelmsen, K. Svardsudd, K. Korsan-Bengtsen, B. Larsson, L. Welin, and G. Tibblin, Fibrinogen as a risk factor for stroke and myocardial infarction, N. Engl.J. Med.

    Google Scholar 

  13. N. Cristal, A. Slonim, I. Bar-Ilan, and A. Hart, Plasma fibrinogen levels and the clinical course of acute myocardial infarction, Angiology 34:693 (1983).

    Article  CAS  PubMed  Google Scholar 

  14. N. T.J. O’Connor, S. Cederholm-Williams, S. Copper, and L. Cotter, Hypercoagulability and coronary artery disease, Br. Heart J. 52:614 (1984).

    Article  PubMed  PubMed Central  Google Scholar 

  15. A. Hamsten, M. Blomback, B. Wiman, J. Svensson, A. Szamosi, U. de Faire, and L. Mettinger, Haemostatic function in myocardial infarction. Br. Heart J. 55:58 (1986).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  16. T. W. Meade, R. Chakrabarti, A.P. Haines, W.R.S. North, and Y. Stirling, Characteristics affecting fibrinolytic activity and plasma fibrinogen concentrations. Br.Med.J. 1:153 (1979).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  17. A. Hamsten, U. De Faire, L. Iselius, and M. Blomback, Genetic and cultural inheritance of plasma fibrinogen concentration. Lancet 11:988 (1987).

    Article  Google Scholar 

  18. S. E. Humphries, M. Cook, M. Dubowtiz, Y. Stirling, and Meade TW, Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentration. Lancet 1:1452 (1987).

    Article  CAS  PubMed  Google Scholar 

  19. I. K. Murray, K. Buetow, D. Chung, and A. Aschbacher, Linkage disequilibrium of RFLP’s at the beta fibrinogen (FGB) and gamma fibrinogen (FGG) loci on chromosome 4. Cytogenet, Cell Genet. 40:707 (1985).

    Article  Google Scholar 

  20. R. L. Ridolfi, and B.M. Hutchins, The relationship between coronary artery lesions and myocardial infarcts: ulceration of atherosclerotic plaques precipitating coronary thrombosis. Am. Heart J. 93:468 (1977).

    Article  CAS  PubMed  Google Scholar 

  21. M. J. Davies, and A. Thomas, Thrombosis and acute coronary-artery lesions in sudden cardiac ischemic death. N. Engl. J. Med. 310:1137 (1984).

    Article  CAS  PubMed  Google Scholar 

  22. J. E. Saffitz, R.C. Fredrickson, and W.C. Roberts, Relation of size of transmural acute myocardial infarction impact to mode of death, interval between infarction and death and frequency of coronary arterial thrombus. Am. J. Cardiol. 57:1249 (1986).

    Article  CAS  PubMed  Google Scholar 

  23. M. J. Davies, Thrombosis in acute myocardial infarction and sudden death, Cardiovasc. Clin. 18:151 (1987).

    CAS  Google Scholar 

  24. M. A. De Wood, J. Spores, R. Notske, L.T. Mouser, R. Burroughs, M.S. Golden, and H.T. Lang, Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction, N. Engl. J. Med.303:897 (1980).

    Article  Google Scholar 

  25. J. A. Ambrose, S.L. Winters, R.R. Arora, J.I. Haft, J. Goldstein, K.P. Rentrop, R. Gorlin, and V. Fuster, Coronary angiographic morphology in myocardial infarction: a link between the pathogenesis of unstable angina and myocardial infarction, J. Am. Coll. Cardiol. 6:1233 (1985).

    Article  CAS  PubMed  Google Scholar 

  26. R. J. Frink, P.A. Rooney, J.O. Trowbridge, and J.P. Rose, Coronary thrombosis and platelet:fibrin microemboli in death associated with acute myocardial infarction, Br. Heart J. 59:196 (1988).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. E. Falk, Unstable angina pectoris with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion, Circulation.71:699 (1985).

    Article  CAS  PubMed  Google Scholar 

  28. M. J. Davies, and A.C. Thomas: Plaque fissuring-the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina, Br.Heart J. 53:363 (1985).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. V. Fuster, and J.H. Chesebro, Mechanisms of unstable angina, N. Engl. J. Med. 315:1023 (1986).

    Article  CAS  PubMed  Google Scholar 

  30. A. H. Kragel, S.G. Reddy, J.T. Wittes, and W.C. Roberts, Morphometric analysis of the composition of atherosclerotic plaques in the four major epicardial coronary arteries in acute myocardial infarcation and in sudden coronary death. Circulation 80:1747 (1989).

    Article  CAS  PubMed  Google Scholar 

  31. E. B. Smith, K.M. Alexander, and I.B. Massie, Insoluble “fibrin”, soluble fibrinogen and low density lipoprotein. Atherosclerosis 23:19 (1976).

    Article  CAS  PubMed  Google Scholar 

  32. E. B. Smith, E.M. Staples, H.S. Dietz, and R.H. Smith, Role of endothelium in sequestration of lipoprotein and fibrinogen in aortic lesions, thrombi, and graft pseudo-intimas. Lancet 1:8812 (1979).

    Google Scholar 

  33. E. B. Smith, and E.M. Staples, Intimal and medial plasma protein concentrations and endothelial function. Atherosclerosis 41:295 (1982).

    Article  CAS  PubMed  Google Scholar 

  34. E. B. Smith, G.A. Keen, A. Grant, and C. Stirk, Fate of fibrinogen in human arterial intima. Arteriosclerosis 10:263 (1990).

    Article  CAS  PubMed  Google Scholar 

  35. S. Sadoshima, and E. Tanaka, Fibrinogen and low density lipoprotein in the development of cerebral atherosclerosis. Atherosclerosis 34:93 (1979).

    Article  CAS  PubMed  Google Scholar 

  36. Z. D. Grossman, S.F. Rosebrough, J.G. McAfee, G. Subramanian, C.A. Ritter-Hrncirik, L.S. Witanowski, and G. Tillapaugh-Fay, Imaging fresh venous thrombi in the dog with 1–131 and In- Ill labeled fibrin-specific monoclonal antibody and its F(ab’)2 and Fab fragments. Radiographics 7:913 (1987).

    Article  CAS  PubMed  Google Scholar 

  37. S. F. Rosebrough, Z.D. Grossman, J.G. McAfee, B.J. Kudryk, G. Subramanian, C.A. Ritter-Hrncirik, L.S. Witanowski, G. Tillapaugh-Fay, Urrutia, and C. Zapf-Longo, Thrombus imaging with indium-Ill and iodine-131-labeled fibrin-specific monoclonal antibody and its F(ab’)2 and Fab fragments, J. Nucl. Med. 29:1212 (1988).

    PubMed  CAS  Google Scholar 

  38. B. J. Kudryk, A. Bini, S.F. Rosebrough, and T.F. Schaible, Fibrinogen-fibrin: preparation and use of monoclonal antibodies as diagnostics, in:Biotechnology of Blood, Stoneham, MA, (ed): Butterworths (1990, in press).

    Google Scholar 

  39. K. Y. Hui, E. Haber, and G.R. Matsueda, Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen. Science 222:1129 (1983).

    Article  CAS  PubMed  Google Scholar 

  40. M. Jung, K. Kletter, R. Dudczak, R. Koppensteiner, E. Minar, and P. Kahls, A. Stumpflen, P. Pokieser, and H. Ehringer, Deep vein thrombosis: Scintigraphic diagnosis with In-111- labeled monoclonal antifibrin antibodies. Radiology 173:469 (1989).

    Article  CAS  PubMed  Google Scholar 

  41. L. Lusiani, P. Zanco, A. Visona, G. Breggion, A. Pagnan, and G. Ferlin, Immunoscintigraphic detection of venous thrombosis of the lower extremities by means of human antifibrin monoclonal antibodies labeled with 111In, Angiology 40:671 (1989).

    Article  CAS  PubMed  Google Scholar 

  42. A. Alavi, H. Palevsky, N. Gupta, M.A. Kelley, A.D. Jatlow, J.F. Schaible, J. Brown, and H.J. Berger, Radiolabelled antifibrin antibody in the detection of venous thrombosis: preliminary results, Radiology 175:79 (1990).

    Article  CAS  PubMed  Google Scholar 

  43. A. Nordoy, and S.H. Goodnight, Dietary lipids and thrombosis. Relationships to atherosclerosis. Arteriosclerosis 10:149 (1990).

    Article  CAS  PubMed  Google Scholar 

  44. M. L. Burr, J.F. Gilbert, R.M. Holloday, P.C. Elwood, A.M. Fehily, S. Rogers, P.M. Sweetnam, and N.M. Deadman, Effects of changes in fat, fish, and fibre intakes in death and myocardial infarction/diet and reinfarction trial (DART), Lancet 11:757 (1989).

    Article  Google Scholar 

  45. J. C. La Rosa, D. Hunninghake, D. Bush, M.H. Criqui, G.S. Getz, A.M. Gotto, S.M. Grundy, L. Rakita, R.M. Robertson, M.L. Weisfeldt, and J.I. Gleeman, Task Force on Cholesterol Issues, American Heart Association: The cholesterol facts. A summary of the evidence relating dietary fats, serum cholesterol, and coronary heart disease. Circulation 81:1721 (1990).

    Article  Google Scholar 

  46. E. Ernst, T. Weihmayr, V. Schmid, M. Baumann, and A. Matrai, Cardiovascular risk factors and hemorheology. Physical fitness, stress and obesity, Atherosclerosis 59:263 (1986).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Consorzio Mario Negri Sud, Istituto di Ricerche Farmacologiche Mario Negri, S. Maria Imbaro, Italy

    Alessandra Bini

  2. Department of Pathology, College of Physicians and Surgeons of Columbia University, New York, USA

    Alessandra Bini

  3. Lindsley F. Kimball Research Institute, The New York Blood Center, New York, USA

    Bohdan J. Kudryk

Authors
  1. Alessandra Bini
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bohdan J. Kudryk
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Chicago Medical Center, Chicago, Illinois, USA

    Robert W. Wissler  & Gertrud Friedman  & 

  2. Bowman-Gray School of Medicine, Winston-Salem, North Carolina, USA

    M. Gene Bond  & Michele Mercuri  & 

  3. University of Siena, Siena, Italy

    Piero Tanganelli  & Giorgio Weber  & 

Rights and permissions

Reprints and permissions

Copyright information

© 1991 Plenum Press, New York

About this chapter

Cite this chapter

Bini, A., Kudryk, B.J. (1991). Use of Monoclonal Antibodies to Fibrinogen, Fibrin and Fibrin(Ogen) Degradation Products in Atherosclerosis. In: Wissler, R.W., Bond, M.G., Mercuri, M., Tanganelli, P., Weber, G., Friedman, G. (eds) Atherosclerotic Plaques. Nato ASI Series, vol 219. Springer, New York, NY. https://doi.org/10.1007/978-1-4757-0438-9_21

Download citation

  • DOI: https://doi.org/10.1007/978-1-4757-0438-9_21

  • Publisher Name: Springer, New York, NY

  • Print ISBN: 978-1-4757-0440-2

  • Online ISBN: 978-1-4757-0438-9

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation